This cell-resolved evidence provides a concrete map of how PGE2 signaling is organized in GBM: a myeloid-centered loop where TAM-derived prostaglandins modulate CD4+ T-cell behavior, establishing an “inflamed but ineffective” immune microenvironment. The gene discussed is CD4; the disease is glioblastoma.